peptideallianceStandard v1.1

Seller record · research vendor · biotechpeptides.com

Biotech Peptides

A research-chemical vendor selling peptide vials with open carts and per-lot certificates of analysis. It states plainly that it is not a pharmacy.

Passes 5 of 8 criteria. Recorded against Standard v1.1, August 2026.

Operating entity Footer, contact, terms and privacy were read, and no legal entity name appears on any of them.

Dispositions at a glance

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician appears on the pages read, and the terms say products are to be handled by licensed or qualified professionals only.Source: biotechpeptides.com/terms-and-conditions · read August 2026.
S2FAILThe order path was walked from the product page and stopped at an age and research-use attestation, the only gate offered before the cart.Source: biotechpeptides.com/product/bpc-157 · read August 2026.
S3FAILThe footer states the company is not a compounding pharmacy under 503A and not an outsourcing facility under 503B.Source: biotechpeptides.com · read August 2026.
S4PASSSells no compounded drugs and says so; all products are sold for research, laboratory, or analytical purposes only, and not for human consumption.Source: biotechpeptides.com · read August 2026.
S5PASSA per-lot certificate of analysis is published as a reachable document, reporting 99.94 percent purity by HPLC-UV-MS from MZ Biolabs.Source: biotechpeptides.com/wp-content/uploads/2020/03/COA_BPC-157_5mg_3140013_20260721_BP.pdf · read August 2026.
S6PASSBiotech Peptides at 8275 S Eastern Ave Suite 200, Las Vegas, NV 89123, printed on the contact page with a telephone number.Source: biotechpeptides.com/contact-us · read August 2026.
S7PASSBPC-157 is printed at 52 dollars for 5mg and 92 dollars for 10mg, with no account or intake required.Source: biotechpeptides.com/product/bpc-157 · read August 2026.
S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026.

Products shown on the seller's own pages at the recorded date: BPC-157, TB-500, Semax, Epitalon, DSIP, MOTS-c, sermorelin, peptide blends.

Sellers passing S1, prescriber requirement · every record below dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.